Dr Bruno R. da Costa
Bruno da Costa
Dr. Bruno R. da Costa is a senior scientist at CTSU and an Associate Professor of Clinical Epidemiology at the University of Toronto. He holds a PhD in Clinical Epidemiology and Biostatistics from the University of Bern in Switzerland, along with MSc degrees in Medical Statistics from the University of Leicester in the UK and Physiotherapy from the University of Alberta in Canada.
Since 2009, Bruno has worked as a methodologist and statistician, contributing to the design and analysis of numerous clinical trials, observational studies, and meta-analyses. He was a research fellow at the Institute of Social and Preventive Medicine and a statistician at CTU Bern, the University of Bern’s clinical trials unit from 2009 to 2014. Later, he served as the head of statistics and methodology at the Institute of Primary Health Care and the Department of Cardiology at the University of Bern from 2015 to 2017.
In 2017, Dr. da Costa moved to Toronto to become the Associate Director of the Applied Health Research Centre (AHRC) and Assistant Professor of Clinical Epidemiology at the University of Toronto. He was promoted to Associate Professor in 2019 and served as the Acting Director of the AHRC between 2020 and 2022.
In 2023, he joined CTSU, where he now co-leads the development of a clinical trial methods research programme and serves as trial statistician for various clinical trials. His research focuses on the comparative effectiveness of interventions in cardiovascular and musculoskeletal medicine and on clinical research methods. He has led several influential studies that impacted clinical practice guidelines for osteoarthritis care.
Treatment outcomes of regenerative endodontic therapy in immature permanent teeth with pulpal necrosis: A systematic review and network meta-analysis
Roza da Costa B., (2023), International Endodontic Journal
Impact of Post-PCI FFR Stratified by Coronary Artery
Roza da Costa B., (2023), JACC: Cardiovascular Interventions
Intracluster correlation coefficients in osteoarthritis cluster randomized trials: a systematic review
King LK. et al, (2023), Osteoarthritis and Cartilage
Rationale and Design of the Pullback Pressure Gradient (PPG) Global Registry.
Munhoz D. et al, (2023), Am Heart J
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design.
Cannata F. et al, (2023), J Cardiovasc Med (Hagerstown), 24, 469 - 474